ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0091

Impaired X-Chromosome Inactivation Maintenance in T Cells Is Associated with Features of Reduced Disease Severity in a Toll-Like Receptor 7-Driven Model of Systemic Autoimmunity

Nikhil Jiwrajka1, Zowie Searcy2, Claudia Lovell2, Natalie Toothacre2, Katherine Forsyth2 and Montserrat Anguera2, 1Divison of Rheumatology, Department of Medicine, Hospital of the University of Pennsylvania, Phildelphia, PA, 2Department of Biomedical Sciences, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA

Meeting: ACR Convergence 2023

Keywords: Epigenetics, interferon, Non-coding RNA, T-Lymphocyte, Treg cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0066–0095) T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Many systemic autoimmune rheumatic diseases, including systemic lupus erythematosus (SLE), Sjögren’s syndrome, and systemic sclerosis are highly female-biased. Although these diseases are more prevalent in females, disease severity is often greater in affected males. Transcriptional profiling of tissues from patients with these diseases has consistently revealed a prominent Type 1/2 interferon (IFN)-stimulated gene signature (ISG). The mechanisms by which sex modulates IFN-associated inflammatory responses in autoimmunity is unclear. The X chromosome contains several genes with roles in immune functions and IFN signaling, and our lab has shown that females with SLE exhibit impaired maintenance of X-chromosome inactivation (XCI) in circulating B and T cells. We therefore sought to determine how perturbed XCI maintenance in T cells modulates susceptibility to an inducible model of systemic autoimmunity using a toll-like receptor 7 (TLR7)-driven model associated with a strong ISG signature.

Methods: Female wild-type C57BL/6, CD4cre+Xist+/+ (n= 12; “WT”), and CD4cre+Xistfl/fl (n=4; “Xist CKO”) mice were treated topically with Imiquimod cream (IMQ; a TLR7 agonist; n=9) or Cetaphil lotion (VEH; n=7), thrice weekly for 10 weeks. Serum, spleen, kidney, and lung tissue were harvested upon euthanasia and processed for autoantibody quantitation, flow cytometry, and histology.

Results: Chronic IMQ treatment resulted in marked splenomegaly, T-cell activation, autoantibody production, and dermal, pulmonary, and renal inflammation. IMQ-treated Xist CKO mice tended to exhibit less splenomegaly and autoantibody production, fewer activated CD4+ and CD8+ T cells, and more Foxp3+ (X-linked) regulatory T cells (Tregs) compared to their WT counterparts. Xist CKO mice also tended to exhibit a greater proportion of Tregs expressing Cxcr3, an X-linked chemokine receptor integral for chemotaxis to sites of Type 2 interferon-mediated inflammation that has been shown to variably escape XCI.

Conclusion: These initial data suggest that impaired XCI maintenance in T cells may modulate Type 1/2 interferon-associated inflammation through an expansion of Foxp3+ Tregs, resulting in a less severe phenotype in this TLR7-driven model. Though further validation of these findings in larger experimental cohorts is required, our studies could provide new insights into factors influencing disease severity in female-biased autoimmune diseases associated with strong ISG signatures.


Disclosures: N. Jiwrajka: None; Z. Searcy: None; C. Lovell: None; N. Toothacre: None; K. Forsyth: None; M. Anguera: None.

To cite this abstract in AMA style:

Jiwrajka N, Searcy Z, Lovell C, Toothacre N, Forsyth K, Anguera M. Impaired X-Chromosome Inactivation Maintenance in T Cells Is Associated with Features of Reduced Disease Severity in a Toll-Like Receptor 7-Driven Model of Systemic Autoimmunity [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/impaired-x-chromosome-inactivation-maintenance-in-t-cells-is-associated-with-features-of-reduced-disease-severity-in-a-toll-like-receptor-7-driven-model-of-systemic-autoimmunity/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/impaired-x-chromosome-inactivation-maintenance-in-t-cells-is-associated-with-features-of-reduced-disease-severity-in-a-toll-like-receptor-7-driven-model-of-systemic-autoimmunity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology